david t. rubin m.d. on altrubio’s novel therapeutics for patients with inflammatory bowel disease.
Published 6 months ago • 43 plays • Length 0:29Download video MP4
Download video MP3
Similar videos
-
6:05
dr. david rubin on covid-19 and inflammatory bowel disease (ibd)
-
5:19
in brief: dr. rubin on why havent we found a cure for inflammatory bowel disease
-
43:28
what ibd patients & caregivers should know about the covid-19 vaccines
-
5:37
quickbytes: dr. rubin discusses the goals of ibd treatment
-
1:33:59
ibd insider: patient updates from the 2021 crohn's & colitis congress®
-
27:14
why did i manifest crohn's ibd?
-
10:51
high school graduate reverses crohn's disease with natural medicine!
-
3:45
crohn's disease; my story
-
0:52
save the date for the 2020 crohn’s & colitis congress®
-
1:20:01
being mindful about diet and ibd
-
1:00:05
current controversies in ibd treatment
-
17:16
key insights: mastering clinical challenges and emerging therapies in ibd
-
4:16
what is crohn's disease?
-
1:00:25
role of foods in crohn's disease: impact on inflammation and recovery
-
3:42
achieving remission of crohn's disease
-
1:27:49
data-driven decisions in crohn's disease: positioning patients for success
-
19:06
crohn's disease: mayo clinic radio
-
6:32
the best diet for crohn's disease treatment
-
1:09
complementary medicine for ibd: vitamins, minerals, and herbs
-
25:33
understanding the mechanisms of action of new agents: implications for efficacy and safety
-
29:53
healthy mind and gut: a conversation about ibd and mental health
-
13:19
what are biosimilar therapies and why should we care?